isabelobrien, Author at European Medical Journal - Page 53 of 66

Dr Jerome Kim on vaccines

Dr Jerome Kim, Director General, International Vaccine Institute, discusses pharma’s role in addressing vaccine hesitancy and refusal.

Roundtable: A new dawn for data

How is the data revolution going to impact the marketing and medical functions?

Talking to Dirk Kosche

Dirk Kosche, President, Established Markets, Astellas Pharma Europe, discusses turning innovation into value for patients.

Talking to Jennifer Cain Birkmose

Jennifer Cain Birkmose, Senior Pharmaceutical Leader in Market Access, Patient Access, and Patient Advocacy, discusses clinical trials.

LEO Pharma’s Monica Shaw on access to medicine challenges

Monica Shaw, Executive Vice President, Region EUROPE Plus, LEO Pharma, speaks with GOLD about digital transformation in healthcare

Talking to Vanessa Pott

Vanessa Pott, Director, Global Patient Insights and Advocacy, Merck KGaA, discusses patient advocacy and supporting carers.

Talking to Alexey Cherchago

Alexey Cherchago, Head of Sales Excellence Europe, Sandoz, talks about leadership and the evolving medical sales representative role.

Talking to Denise Dewar

Denise Dewar, Digital Hub Director, Europe, Japan and Canada, GSK, discusses digital transformation and swapping whisky for pharma.

Pulling away from push marketing

While pharmaceutical marketers used to rely heavily on push marketing, since the pandemic, a call to move to pull advertising has prevailed. How can pharma further engage the medical affairs function to draw in doctors with tailored, scientific content that is targeted and trustworthy?

Preparing for the next pandemic

The pharmaceutical industry could have been better prepared for the COVID-19 pandemic. What did they learn that will help them respond better in the future?